Institute of Integrative Omics and Applied Biotechnology

IIOAB


 

 

RESEARCH AREAS 

 

Bioinformatics

Proteomics and Cell Signaling

Cardio-Vascular and Infectious Diseases

Nano-Biotechnology & Systems Biology

Cancer Pharmacogenomics and Personalized Medicine

Plant Genomics and Sustainable Agriculture

Neutrigenomics and Toxicogenomics

Ecology & Environment

Intellectual Property

Renewable Energy 

 

ACHIEVEMENTS

Within this short span IIOAB has published following Books and Research and Review Articles in International and National Journals. Several research articles are under peer-review process. Critical disease signaling pathways and drug targets for five cancers have been identified. Drug and vaccine targets for one of the most common STD are also identified. Drugable Genome Database that consists of genomic drug targets of human  pathogens is under construction. Several Research Reference Books are in press or under process.

 

DEVELOPED

DISEASE PATHWAYS

 

Critical Disease Pathways in Female Breast Cancer

Therapeutic microRNA Targets in Female Breast Cancer

Critical Disease Pathways and Drug Targets in Male Breast Cancer

Critical Disease Pathways and Drug Targets in Cardiac Myxoma

Molecular Mechanism in Cardiogenesis

  

DATABASE 



 

BIOINFORMATICS TOOLS

  

FunSys : for functional analysis of transcriptome and proteome [PMID: 22829724] 
Pannotator : an automated tool for annotation of pan-genomes [PMID: 24065654
DISMIRA: prioritizing disease-miRNA associations   [PMID: 26040329]   NEW
Simplifier : a web tool to eliminate redundant NGS contigs [PMID: 23275695]
G4ALL: for finishing and drafting bacterial genomes [PMID: 23888102]

 

 

 

INTERNATIONAL JOURNALS

 

 

 

 

 

30 Selected International Publications

(Aug, 2008 - Aug, 2014)

 

  

Cancer

  1. E Demir, B Atar, D Dhawan, D Barh, M Gunduz, E Gunduz. [2014]. Breast Cancer Stem Cells and Cellomics. In "Omics Approaches in Breast Cancer", pp. 245-263, Springer, LLC. DOI: 10.1007/978-81-322-0843-3_12
  2. ZN Unal, G Kaya, D Barh, E Gunduz, M Gunduz. [2014]. Omics of Male Breast Cancer. In "Omics Approaches in Breast Cancer", pp. 265-276, Springer, LLC. DOI:10.1007/978-81-322-0843-3_13
  3. M Verma, D Barh. [2014]. Breast Cancer Biomarkers for Risk Assessment, Screening, Detection, Diagnosis, and Prognosis. In "Omics Approaches in Breast Cancer", pp. 393-407, Springer, LLC. DOI: 10.1007/978-81-322-0843-3_20
  4. EC Yiannakopoulou, D Barh. [2014]. Pharmacogenomics–Pharmacoepigenomics of Breast Cancer Therapy: Clinical Implications. In "Omics Approaches in Breast Cancer", pp. 499-518, Springer, LLC. DOI: 10.1007/978-81-322-0843-3_25
  5. Barh D and Gunduz M (Edts): Noninvasive Molecular Markers in Gynecologic Cancers. ISBN: 9781466569386; First Ed: Jan, 2015; Taylor & Francis LLC, USA.(In Press).
  6. Barh D (Edt): Omics approaches in breast cancer: towards next-generation diagnosis, prognosis, and therapy. ISBN: 9788132208426; First Ed: 2014; Springer LLC. 
  7. Barh DDhwan D and Ganguly NK (Edts): Omics for Personalized Medicine. First Ed: 2013; Springer LLC. (In Press)
  8. Barh D, Carpi A, Verma, M, and Gunduz M (Edts): Cancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis. ISBN: 9781466584280; First Ed: Sept, 2013;Taylor & Francis LLC, USA 
  9. Barh D, Jain N, Tiwari S, Field JK, Padin-Iruegas E, Ruibal A, López R, Herranz M, Bhattacharya A, Juneja L, Viero C, Silva A, Miyoshi A, Kumar A, Blum K, Azevedo V, Ghosh P, Liloglou T. [2013]. A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancerBMC Genomics, 14 (Suppl 6), S5 [PubMed: 24564251[IF: 4.07] 
  10. Barh D, Gupta K, Khatri G, Rahangdale S, Verma A. [2012]. An Integrative Omics Strategy for Identification of Skin Cancer Biomarkers. European Journal of Cancer, 48 (S6), 79. [IF: 5.53] 
  11. Barh D, Jain N. A novel omics strategy to identify biomarkers for early diagnosis and classification of lung cancer. Journal of Thoracic Oncology, 2012,  7 (11), S5, Page No-S471 [IF: 3.66]  
  12. Barh D, Malhotra R, Ravi B, Sindhurani P. [2010]. microRNA Let-7: an emerging next-generation cancer therapeutic. Current Oncology; 17 (1), 70-80. [PubMed: 20179807] [IF: 2.47] 
  13. Barh D, Kumar A, Chatterjee S, Liloglou T. [2009]. Molecular features, markers, drug targets, and targeted therapeutics in cardiac myxoma. Current Cancer Drug Targets; 9 (6), 705-716.  [PubMed: 19754355] [IF: 4.3]  
  14. Barh D, Parida S. [2009]. Cardiac myxoma: molecular markers, critical disease pathways, drug targets, and putative targeting miRs. Cancer Therapy; 7, 77-96.
  15. Barh D. [2009]. Biomarkers, critical disease pathways, drug targets, and alternative medicine in male breast cancer. Current Drug Targets; 10, 1-8. [PubMed: 19149530] [IF: 3.93] 
  16. Barh D, Parida S. Parida BP, Viswanathan G. [2008]. Let-7, miR-125, miR-205, and miR-296 are prospective therapeutic agents in breast cancer molecular medicine. Gene Therapy and Molecular Biology; 12, 189-206.

 

Genomics

 

  1. A.R. Santos, E. Barbosa, K. Fiaux, M. Zurita-Turk, V. Chaitankar, B. Kamapantula, A. Abdelzaher, P. Ghosh, S. Tiwari, N. Barve, N. Jain, D. Barh, A. Silva, A. Miyoshi, V. Azevedo. [2013]. PANNOTATOR: an automated tool for annotation of pan-genomes. Genetics and molecular research 12(3):2982-2989 [PMID: 24065654[IF=1.18] 
  2. Carneiro AR, Ramos RT, Barbosa1 HPM, Schneider MPC, Barh D, Azevedo V, Silva A. [2012]. Quality of prokaryote genomes assembly: Indispensable issues of factors affecting prokaryote genome assembly quality. Gene. 505(2):365-7 [PMID: 22721771] [IF: 2.26]
  3. Hassan SS, Schneider MP, Ramos RT, Carneiro AR, Ranieri A, Guimarães LC, Ali A, Bakhtiar SM, Pereira Ude P, Dos Santos AR, Soares Sde C, Dorella F, Pinto AC, Ribeiro D, Barbosa MS, Almeida S, Abreu V, Aburjaile F, Fiaux K, Barbosa E, Diniz C, Rocha FS, Saxena R, Tiwari S, Zambare V, Ghosh P, Pacheco LG, Dowson CG, Kumar A, Barh D, Miyoshi A, Azevedo V, Silva A. [2012]. Whole-Genome Sequence of Corynebacterium pseudotuberculosis Strain Cp162, Isolated from Camel. J Bacteriol; 194(20):5718-19. [PMID: 23012291] [IF: 3.92] 
  4. Cerdeira LT, Pinto AC, Cruz Schneider MP, Silva S, Santos AR, Vieira Barbosa EG, Ali A, Barbosa MS, Carneiro AR, Jucá Ramos RT, Santos O, Barh D, Barve N, Zambare V, Estevão S, Guimarães LC, de Castro S, Dorella FA, Rocha FS, Augusto V, Tauch A, Trost E, Miyoshi A, Azevedo V, Silva A. [2011]. Whole genome sequence of Corynebacterium pseudotuberculosis PAT10 of strain isolated from sheep in Patagonia, ArgentineJournal of Bacteriology, 193(22):6420-1. [PubMed: 22038974] [IF: 3.92]
  5. Cerdeira LT, Carneiro AR, Bol E, Barbosa MS, Coimbra N, Ramos RTJ, Almeida SS, Santos AR, Soares SC, Pinto AC, Ali A, Barbosa E, Dorella FA, Rocha FS, Guimaraes LG, Figueira F, Ghosh P, Zambare V, Barve N, Tiwari S, Barh D, Miyoshi A, Schneider MPC, Azevedo V, Silva A. [2011]. Complete Genome Sequence of Corynebacterium pseudotuberculosis strain - CIP 52.97- isolated from Horse in Kenya. Journal of Bacteriology, 193(24):7025-6. [PubMed: 22123771] [IF: 3.92]
  6. 8 Genome sequences: GenBank: CP003061; GenBank: CP002924.1; GenBank: CP003077.1; GenBank: CP003385.1; GenBank: CP003407.1; GenBank:  CP003421.1; GenBank:  CP003540.1; GenBank:CP003652.1

 

Infectious disease

  1.  SS Hassan, S Tiwari, LC Guimarães, SB Jamal, Barh D et al. [2014]. Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis. BMC Genomics. 15 (Suppl 7), S3. [IF=4.04] NEW
  2. Tiwari S, da Costa MP, Almeida S, Hassan SS, Jamal SB, Oliveira A, Folador EL, Rocha F, de Abreu VA, Dorella F, Hirata R, de Oliveira DM, da Silva Teixeira MF, Silva A, Barh D, Azevedo V. [2014]. C. pseudotuberculosis Phop confers virulence and may be targeted by natural compounds. Integr Biol (Camb). 6(11):1088-99. [PMID: 25212181[IF=4.45]    NEW
  3. Barh D, Barve N, Gupta K, Chandra S, Jain N, et al. [2013]. Exoproteome and Secretome Derived Broad Spectrum Novel Drug and Vaccine Candidates in Vibrio cholerae Targeted by Piper betel Derived Compounds. PLoS ONE 8(1): e52773. doi:10.1371/journal.pone.0052773 [IF: 4.09] 
  4. Barh D, Gupta K, Jain N, Khatri G, León-Sicairos N, Canizalez-Roman A, Tiwari S, et al. [2013]. Conserved host–pathogen PPIs: Globally conserved inter-species bacterial PPIs based conserved host-pathogen interactome derived novel target in C. pseudotuberculosis, C. diphtheriae, M. tuberculosis, C. ulcerans, Y. pestis, and E. coli targeted by Piper betel compounds. Integrative Biology  [PubMed: 23288366 ] DOI: 10.1039/C2IB20206A [IF: 4.5] NEW
  5. Santos AR, Carneiro A, Gala-García A, Pinto A, Barh D, Barbosa E, Aburjaile F, Dorella F, Rocha F, Guimarães L, Zurita-Turk M, Ramos R, Almeida S, Soares S, Pereira U, Abreu VC, Silva A, Miyoshi A, Azevedo V. [2012]. The Corynebacterium pseudotuberculosis in silico predicted pan-exoproteome. BMC Genomics; S5:S6. [PMID: 23095951] [IF: 4.07]
  6. Barh D, Jain N, Tiwari S, Parida BP, D'Afonseca V, Li L, Ali A, Santos AR, Guimarães LC, de Castro Soares S, Miyoshi A, Bhattacharjee A, Misra AN, Silva A, Kumar A, Azevedo V. [2011]. A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogensChemical Biology & Drug Design; 78(1):73-84.  [PubMed: 21443692] [IF: 2.47] 
  7. Barh D, Misra AN, Kumar A, Vasco A. [2010]. A novel strategy of epitope design in Neisseria gonorrhoeae. Bioinformation; 5 (2), 77-85. [PubMed: 21346868] [IF: 1.15]
  8. Barh D and Kumar A. [2009]. In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae. In Silico Biol.; Vol. 9, 0019. [PubMed: 20109152] [Cited in Nature Reviews Microbiology, 9(7): 2011

 

Neuropsychiatric and metabolic disease

  1.  Blum K, Oscar-Berman M, Demetrovics Z, Barh D, Gold MS. [2014]. Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS). Mol Neurobiol. 50(3):765-96. [PMID: 24878765] [IF=6.0] NEW
  2. Miller M, Chen A, Stokes A, Silverman S, Bowirrat A, Manka M, Manka D, Miller D, Perrine K, Chen T, Bailey J, Downs BW, Waite R, Madigan M, Braverman E, Damle U, Kerner M, Giordano J, Morse S, Oscar-Berman M, Barh D, Blum K. [2012]. Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves Behavioral Outcomes in a Residential Addiction Treatment Program: A Pilot StudyJournal of Psychoactive Drugs. DOI:10.1080/02791072.2012.737727 [IF: 1.72]  
  3. Blum K, Giordano J, Oscar-Berman M, Bowirrat A, Simpatico T, Barh D. [2012]. Diagnosis and Healing In Veterans Suspected of Suffering from Post-Traumatic Stress Disorder (PTSD) Using Reward Gene Testing and Reward Circuitry Natural Dopaminergic Activation. J Genet Syndr Gene Ther. 31;3(3):1000116. [PMID: 23264885]
  4. Blum K, Chen ALC, Giordano J, Borsten J, Chen TJH, Hauser M, Simpatico T, Femino J, Braverman ER, Barh D. [2012]. The Addictive Brain: All Roads Lead to Dopamine. Journal of Psychoactive Drugs, 44 (2), 134–143. [PubMed: 22880541] [IF: 1.72]
  5. Chen ALC, Blum K, Chen TJH, Giordano J, Downs BW, Han D, Barh D, Braverman ER. [2012]. Correlation of the Taq1 Dopamine D2 Receptor Gene and Percent Body Fat in Obese and Screened Control Subjects: A Preliminary ReportFood & Function; 3(1):40-8. [PubMed: 22051885] [IF: 1.17]
  6. Morse S, Giordano J, Perrine K, Downs BW, Waite RL, Madigan M, Bailey J, Braverman ER,  Damle U, Knopf J, Simpatico T, Moeller MD, Barh D, Blum K. [2011]. Audio Therapy Significantly Attenuates Aberrant Mood in Residential Patient Addiction Treatment: Putative Activation of Dopaminergic Pathways in the Meso-Limbic Reward Circuitry of Humans. J Addict Res Ther;  S3:001. doi:10.4172/2155-6105.S3- 001
  7. Blum K, Chen TJH, Bailey J, Bowirrat A, Femino J, Chen ALC, Madigan M, Simpatico T, Morse S, Giordano J, Damle U, Kerner M, Braverman ER, Fornari F, Downs BW, Rector C, Barh D, Berman MC. [2011]. Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential? Molecular Neurobiology; 44(3):250-68. [PubMed: 21948099] [IF: 6.068]
  8. Blum K, Chen ALC, Oscar-Berman M, Chen TJH, Lubar J, White N, Lubar J, Bowirrat A, Braverman E, Schoolfield J, Waite RL, Downs BW, Madigan M, Comings DE, Davis C, Kerner MM, Knopf J, Palomo T, Giordano JJ, Morse SA, Fornari F, Barh D, Femino J, Bailey JA.  [2011]. Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects: Selecting Appropriate Phenotypes for Reward Dependence BehaviorsInt J Env Res Public Health; 8(12):4425-4459. [PubMed: 22408582] [IF: 1.6]

 

Agri, Biotechnology, and Bioprocess

  1. Barh, Khan and Davies (Edts.) PlantOmics: The Omics of Plant Science. ISBN: 978-81-322-2171-5; ; First Ed: 2015; Springer, LLC. (In Press).
  2. Jha UC, Chaturvedi SK, Bohra A, Basu PS, Khan MS, Barh D. [2014]. Abiotic stresses, constraints, and improvement strategies in chickpea. Plant Breeding, DOI: 10.1111/pbr.12150.  [IF=1.8]
  3. Bohra A, Jha UC, Singh B, Soren KR, Singh IP, Chaturvedi SK, Nadarajan N, and Barh D: [2014]. Omics Approaches in Pulses. In “OMICS Applications in Crop Science” ISBN 9781466585256, Edt by Barh D. Taylor & Francis LLC, USA .
  4. Barh D (Edt). [2014]. OMICS Applications in Crop Science. Taylor & Fransis LLC, USA, ISBN: 9781466585256
  5. Barh D, Yiannakopoulou UC, SALAWU UO, Bhattacharjee A, Chowbina S, Ghosh P, Azevedo V: In silico disease models. In “Animal Biotechnology: Models in Discovery and Translation”, [2012], Edt by Verma and Singh. Elsevier, USA 
  6. Hemaiswarya S, Raja R, Carvalho IS, Ravikumar R, Zambare V, Barh D. [2012].  An Indian scenario on renewable and sustainable energy sources with emphasis on algae. Appl Microbiol Biotechnol; 96(5):1125-35. [PMID: 23070650] [IF: 3.42] 
  7. Hollmann A, Saviello M, Delfederico L, Saraiva TDL, Barh D, Chandra S, Gupta K, Jain N, Zambare V, Kumar A, Misra AN, Christopher L, Azevedo V, Semorile L, Miyoshi A. [2012]. Tight controlled expression and secretion of Lactobacillus brevis SlpA in Lactococcus lactis. Biotechnology Letters; 34(7):1275-81. [PubMed: 22391736] [IF: 1.76]
  8. Zambare V. Zambare A, Barh D, Christopher LP. [2012]. Optimization of enzymatic hydrolysis of prairie cordgrass for improved ethanol production. J. Renewable Sustainable Energy 4, 033118 [IF: 0.885]
  9. Barh D, Ahmad S, and Bhattacharjee A: In silico and ultra-high throughput screenings (uHTS) in drug discovery: an overview. In “Pharmaceutical Biotechnology (2nd Ed)”, [2012], ISBN: 978-3-527-32994-6. Edt by Oliver Kayser and Herbert Warzecha. Wiley-VCH Verlag GmbH & Co, Germany. 
 
 

 Genome Sequence Published

 

  1. Corynebacterium pseudotuberculosis CIP 52.97, complete genomeGenBank: CP003061
  2. Corynebacterium pseudotuberculosis PAT10, complete genome. GenBank: CP002924.1
  3. Corynebacterium pseudotuberculosis 316, complete genome. GenBank: CP003077.1
  4. Corynebacterium pseudotuberculosis P54B96, complete genome. GenBank: CP003385.1
  5. Corynebacterium pseudotuberculosis 267, complete genome. GenBank: CP003407.1
  6. Corynebacterium pseudotuberculosis 31, complete genome. GenBank:  CP003421.1
  7. Corynebacterium pseudotuberculosis 258, complete genome. GenBank:  CP003540.1
  8. Corynebacterium pseudotuberculosis Cp162, complete genome. GenBank:  CP003652.1

 

10 more genomes are in the sequencing pipeline including 4 deadly pathogens of Indian origin

 

 

 PEER-REVIEWED ALL PUBLICATIONS AND PROCEEDINGS  

(Aug, 2008 - May, 2015)

 2015 

More coming soon.........! 

 

  1. Barh D, Kamapantula B, Jain N, Nalluri J, Bhattacharya A, Juneja L, Barve N, Tiwari S, Miyoshi A, Azevedo V, Blum K, Kumar A, Silva A, Ghosh P. [2015]. miRegulome: a knowledge-base of miRNA regulomics and analysis.. Nature Scientific reports, 5:12832. doi: 10.1038/srep12832. [IF=5.75] NEW
  2. Nalluri JJ, Kamapantula BK, Barh D, Jain N, Bhattacharya A, de Almeida SS, Ramos RTJ, Silva A, Azevedo V, Ghosh P. [2015]. DISMIRA: Prioritization of disease candidates in miRNA-disease associations based on maximum weighted matching inference model and motif-based analysis. BMC Genomics. 16(Suppl 5):S12. DOI:10.1186/1471-2164-161471-2164-16-S5-S12 [IF=4.04]
  3. Radusky LG, Hassan SS, Lanzarotti E, Tiwari S, Jamal SB, Ali J, Ali A, Ferreira RS, Barh D, Silva A, Turjanski AG, Azevedo V. [2015]. An Integrated Structural Proteomics Approach Along The Druggable Genome of Corynebacterium Pseudotuberculosis Species For Putative Druggable Targets. BMC Genomics, DOI:10.1186/1471-2164-161471-2164-16-S5-S9  [IF=4.04]
  4. Guimarães LS, de Castro S, Trost E, Blom J, Ramos RTJ, Silva A, Barh D, Azevedo V. [2015]. Genome informatics and vaccine targets in Corynebacterium urealyticum using two whole genomes, comparative genomics, and reverse vaccinology. BMC Genomics. 16((Suppl 5):S7). DOI:10.1186/1471-2164-16-S5-S7 [IF=4.04]
  5. Kumavath RN, Ramana ChV, Sasikala Ch, Barh D, Kumar AP, Azevedo V. [2015]. Isolation and characterization of L-tryptophan ammonia lyase from Rubrivivax benzoatilyticus strain JA2. Curr Protein Pept Sci. DOI:10.2174/1389203716666150505235929 [PubMed: 25961404] [IF=2.33] 
  6. Foladora EL, de Oliveira AF, Jamala SB, Silva A, Ferreira SR, Barh D, Ghosh P, Azevedoa V. [2015]. In silico protein-protein interactions: avoiding data and method biases over sensitivity and specificity. Curr Protein Pept Sci. DOI:10.2174/1389203716666150505235437 [PubMed: 25961403] [IF=2.33]
  7. Ali A, Naz A, Soares SC, Bakhtiar M, Tiwari S, Hassan SS, Hanan F, Ramos R, Pereira U, Barh D, Figueiredo HC, Ussery DW, Miyoshi A, Silva A, Azevedo V. [2015]. Pan-Genome Analysis of Human Gastric Pathogen H. pylori: Comparative Genomics and Pathogenomics Approaches to Identify Regions Associated with Pathogenicity and Prediction of Potential Core Therapeutic Targets. Biomed Res Int.. 2015:139580 [PubMed: 25705648] [IF=2.7]  

 

 

 2014 

  1.  E Demir, B Atar, D Dhawan, D Barh, M Gunduz, E Gunduz. [2014]. Breast Cancer Stem Cells and Cellomics. In "Omics Approaches in Breast Cancer", pp. 245-263, Springer, LLC. DOI: 10.1007/978-81-322-0843-3_12
  2. ZN Unal, G Kaya, D Barh, E Gunduz, M Gunduz. [2014]. Omics of Male Breast Cancer. In "Omics Approaches in Breast Cancer", pp. 265-276, Springer, LLC. DOI: 10.1007/978-81-322-0843-3_13
  3. M Verma, D Barh. [2014]. Breast Cancer Biomarkers for Risk Assessment, Screening, Detection, Diagnosis, and Prognosis. In "Omics Approaches in Breast Cancer", pp. 393-407, Springer, LLC. DOI: 10.1007/978-81-322-0843-3_20
  4. EC Yiannakopoulou, D Barh. [2014]. Pharmacogenomics–Pharmacoepigenomics of Breast Cancer Therapy: Clinical Implications. In "Omics Approaches in Breast Cancer", pp. 499-518, Springer, LLC. DOI: 10.1007/978-81-322-0843-3_25
  5. Ali A, Naz A, Soares SC, Bakhtiar M, Tiwari S, Hassan SS, Hanan F, Ramos R, Pereira U, Barh D et al. [2014]. Pan-Genome Analysis of Human Gastric Pathogen H. pylori: Comparative Genomics and Pathogenomics Approaches to Identify Regions Associated with Pathogenicity and Prediction of Potential Core Therapeutic Targets. BioMed Research International. Article ID 139580. doi.org/10.1155/2014/139580 [IF=2.7] 
  6. SS Hassan, S Tiwari, LC Guimarães, SB Jamal, Barh D et al. [2014]. Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis. BMC Genomics. 15 (Suppl 7), S3. [IF=4.04] 
  7. Devarapalli P, Kumavath RN, Barh D, Azevedo V. [2014]. The conserved mitochondrial gene distribution in relatives of Turritopsis nutricula, an immortal jellyfish. Bioinformation.10(9):586-91. [PMID: 25352727]
  8. Tiwari S, da Costa MP, Almeida S, Hassan SS, Jamal SB, Oliveira A, Folador EL, Rocha F, de Abreu VA, Dorella F, Hirata R, de Oliveira DM, da Silva Teixeira MF, Silva A, Barh D, Azevedo V. [2014]. C. pseudotuberculosis Phop confers virulence and may be targeted by natural compounds. Integr Biol (Camb). 6(11):1088-99. [PMID: 25212181[IF=4.45]   
  9. Folador EL, Hassan SS, Lemke N, Barh D, Silva A, Ferreira RS, Azevedo V. [2014]. An improved interolog mapping-based computational prediction of protein-protein interactions with increased network coverage. Integr Biol (Camb). 6(11):1080-7. [PMID: 25209055] [IF=4.45] 
  10. Bakhtiar SM, Ali A, Baig SM, Barh D, Miyoshi A, Azevedo V. [2014]. Identifying human disease genes: advances in molecular genetics and computational approaches. Genet Mol Res.13(3):5073-87. [PMID: 25061732] [IF=1.18] 
  11. Blum K, Oscar-Berman M, Waite RL, Braverman ER, Kreuk F, Li M, Dushaj K, Madigan MA, Hauser M, Simpatico T, Barh D. [2014]. A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain. J Genet Syndr Gene Ther. 5(1):213. [PMID: 24883230]
  12. M Verma, D Barh, N Jain. [2014]. Noninvasive Early Markers in Lung Cancer. In "Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis", Edt by Barh et al. ISBN: 9781466584280, pp. 415-431. Taylor & Francis LLC, USA, DOI: 10.1201/b16389-23
  13. K Blum, M Oscar-Berman, SH Blum, MA Madigan, RL Waite, M Thomas, Barh D. [2014]. Alcoholism & Drug Dependence. J Alcohol Drug Depend. 2:3. DOI: 0.4172/2329-6488.1000161
  14. Blum K, Oscar-Berman M, Demetrovics Z, Barh D, Gold MS. [2014]. Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS). Mol Neurobiol. 50(3):765-96. [PMID: 24878765]
  15. Blum K, Oscar-Berman M, Downs W, Braverman ER, Kreuk F, Dushaj K, Truesdell C, Li M, Giordano J, Borsten J, Simpatico T, Barh D, Madigan MA, Jones S, Schoenthaler S. [2014]. Hypothesizing that Putative Dopaminergic, Melatonin, Benzodiazepine Reward Circuitry Receptor(s) Activator Provides Sleep Induction Benefits. Journal of Sleep Disorders & Therapy, 3(153). DOI:10.4172/2167-0277.1000153
  16. Blum K, Oscar-Berman M, Waite RL, Braverman ER, Kreuk F, Li M, Dushaj K, Madigan MA, Hauser M, Simpatico T, Barh D. [2014]. A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain. Journal of Genetic Syndromes & Gene Therapy, 5: 213. DOI:10.4172/2157-7412.1000213
  17. RL Waite, M Oscar-Berman, E RBraverman, D Barh, K Blum. [2014]. Quantitative Electroencephalography Analysis (qEEG) of Neuro-Electro-Adaptive Therapy 12™[NEAT12] Up-Regulates Cortical Potentials in an Alcoholic during Protracted Abstinence: Putative Anti-Craving Implications. J Addict Res Ther. 5:1. DIO: 0.4172/2155-6105.1000171
  18. Jha UC, Chaturvedi SK, Bohra A, Basu PS, Khan MS, Barh D. [2014]. Abiotic stresses, constraints, and improvement strategies in chickpea. Plant Breeding, DOI: 10.1111/pbr.12150.  [IF=1.8]
  19. Bohra A, Jha UC, Singh B, Soren KR, Singh IP, Chaturvedi SK, Nadarajan N, and Barh D: [2014]. Omics Approaches in Pulses. In “OMICS Applications in Crop Science” ISBN 9781466585256, Edt by Barh D. Taylor & Francis LLC, USA .
  20. Barh D (Edt). [2014]. OMICS Applications in Crop Science. Taylor & Fransis LLC, USA, ISBN: 9781466585256

 

2013

  1. Blum K, Han D, Giordano J, Lohmann R,  Braverman ER, Madigan MA,  Barh D, Femino J, Hauser M, Downs BW, Simpatico T: [2013]. Neurogenetics and Nutrigenomics of Reward Deficiency Syndrome (RDS): Stratification of Addiction Risk and Mesolimbic Nutrigenomic Manipulation of Hypodopaminergic Function. In “Omics for Personalized Medicine”  ISBN: 9788132211839 . Edt by Barh D, Dhawan D, Ganguly NK. Springer, India
  2. Blum K , Han D, Oscar-Berman M, Reinl G, DiNubile N, Madigan M, Bajaj A, Downs B, Giordano J, Westcott W, Smith L, Braverman E, Dushaj K, Hauser M, Simpatico T, McLaughlin T, Borsten J, Barh D. [2013]. Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs. Health, 5, 16-34. doi: 10.4236/health.2013.511A1004
  3. Nalluri J, Kamapantula B, Barh D, Ghosh P, Jain N, Juneja L, Barve N. [2013]. Determining miRNA-disease associations using Bipartite Graph Modelling. ACM 978-1-4503-2434-2/13/09. BCB ’13, September 22 - 25, 2013, Washington, DC
  4. U.P. Pereira, S.C. Soares, J. Blom, C.A.G. Leal, R.T.J. Ramos, L.C. Guimarães, L.C. Oliveira, S.S. Almeida, S.S. Hassan, A.R. Santos, A. Miyoshi, A. Silva, A. Tauch, D. Barh, V. Azevedo, H.C.P. Figueiredo. [2013]. In silico prediction of conserved vaccine targets in Streptococcus agalactiae strains isolated from fish, cattle, and human samples. Genetics and molecular research 12(3):2902 – 2912 [PMID: 24065646]  [IF=1.18]
  5. A.R. Santos, E. Barbosa, K. Fiaux, M. Zurita-Turk, V. Chaitankar, B. Kamapantula, A. Abdelzaher, P. Ghosh, S. Tiwari, N. Barve, N. Jain, D. Barh, A. Silva, A. Miyoshi, V. Azevedo. [2013]. PANNOTATOR: an automated tool for annotation of pan-genomes. Genetics and molecular research 12(3):2982-2989 [PMID: 24065654[IF=1.18] 
  6. Blum K, Thompson B, Oscar-Berman M, Giordano J, Braverman E, Femino J, Barh D, Downs W, Smpatico T, Schoenthaler S. [2013]. Genospirituality: Our Beliefs, Our Genomes, and Addictions. J Addict Res Ther. 5(4). pii: 162. [PMID: 24971227]  
  7. Barh D, Jain N, Tiwari S, Field JK, Padin-Iruegas E, Ruibal A, López R, Herranz M, Bhattacharya A, Juneja L, Viero C, Silva A, Miyoshi A, Kumar A, Blum K, Azevedo V, Ghosh P, Liloglou T. [2013]. A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancerBMC Genomics, 14 (Suppl 6), S5 [PMID: 24564251] [IF: 4.07] 
  8. Hill E, Han D, Dumouchel P, Dehak N, Quatieri T, Moehs C, Oscar-Berman M, Giordano J, Simpatico T, Barh D, Blum K. [2013]. Long term suboxone™ emotional reactivity as measured by automatic detection in speech. PLoS One. 2013 Jul 9;8(7):e69043. [PubMed: 23874860] [IF=4.09]
  9. Downs BW, Oscar-Berman M, Waite RL, Madigan MA, Giordano J, Beley T, Jones S, Simpatico T, Hauser M, Borsten J, Marcelo F, Braverman ER, Lohmann R, Dushaj K, Helman M, Barh D, Schoenthaler ST, Han D, Blum K. [2013]. Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™. J Genet Syndr Gene Ther 4: 136.  [PMID: 24077767]
  10. Ramos RTJ, Carneiro AR, Caracciolo PH, Azevedo V, Schneider MPC, Barh D, Silva A. [2013]. Graphical Contig Analyzer for All Sequencing Platforms (G4ALL): a new stand-alone tool for finishing and draft generation of bacterial genomes. Bioinformation 9(11):599-604. [PubMed: 23888102]  [IF=1.15]
  11. Blum K, Foster Olive M, Wang KK, Febo M, Borsten J, Giordano J, Hauser M, Gold MS. [2013] Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption. Med Hypotheses. 81(3):450-455. [PubMed: 23845561] [IF=1.05]
  12. Archer T, Oscar-Berman M, Blum K, Gold M. [2013]. Epigenetic Modulation of Mood Disorders. J Genet Syndr Gene Ther. 4(120). pii: 1000120. [PubMed: 23565345] 
  13. Blum K, Oscar-Berman M, Dinubile N, Giordano J, Braverman ER, Truesdell CE, Barh D, Badgaiyan R. Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence. J Addict Res Ther. 2013 Oct 31;4(163):1000163. [PMID: 24616834]
  14. Yarnell S, Oscar-Berman M, Avena N, Blum K, Gold M. [2013]. Pharmacotherapies for Overeating and Obesity. J Genet Syndr Gene Ther. 4(3):131. [PubMed: 23826512] 
  15. Silva WM, Seyffert N, Ciprandi A, Santos AV, Castro TLP, Pacheco LGC, Barh D, Loir YL, Pimenta AMC, Miyoshi A, Artur Silva A,  Azevedo V. [2013]. Differential Exoproteome Analysis of Two Corynebacterium pseudotuberculosis Biovar Ovis Strains Isolated from Sheep (1002) and Goat (C231). Curr Microbiol. [PMID: 23699973] [IF: 1.8]
  16. Kushner S, Han D, Oscar-Berman M, Downs WB, Madigan MA, Giordano J, Beley T, Jones S, Barh D, Simpatico T, Dushaj K, Lohmann R, Braverman ER, Schoenthaler S, Ellison D, Blum K. [2013]. Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study. J Addict Res Ther, 4: 153. [PMID: 24273684]
  17. Mclaughlin T, Oscar-Berman M, Simpatico T, Giordano J, Jones S, Barh D, Downs, Waite RL, Madigan M, Dushaj K, Lohmann R, Braverman ER, Han D,  Blum K. [2013]. Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette’s syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT). Journal of Behavioral Addictions, 2 (2): 117-124, DOI: 10.1556/JBA.2.2013.2.8
  18. Silva WM, Seyffert N, Santos AV, Castro TL, Pacheco LG, Santos AR, Ciprandi A, Dorella FA, Andrade HM, Barh D, Pimenta AM, Silva A, Miyoshi A, Azevedo V. [2013]. Identification of 11 new exoproteins in Corynebacterium pseudotuberculosis by comparative analysis of the exoproteome. Microb Pathog. [PMID: 23684727] [IF: 2.1]
  19. Blum K, Oscar-Berman M, Femino J, Waite RL, Benya L, Giordano J, Borsten J, Downs WB, Braverman ER, Loehmann R, Dushaj K, Han D, Simpatico T, Hauser M, Barh D, McLaughlin T. [2013]. Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note. J Addict Res Ther 4: 146. [PMID: 24273683]
  20. Barh D and Vedamurthy AB. [2013]. Therapeutic potential of Let-7, miR-125, miR-205, and miR-296 in breast cancer: An update. The IIOAB Journal. 4 (1): 25-26
  21. Ali A, Soares SC, Barbosa E, Santos AR, Barh D, Bakhtiar SM, Hassan SS, Ussery DW, Silva A, Miyoshi A, Azevedo V. [2013]. Microbial Comparative Genomics: An Overview of Tools and Insights Into The Genus Corynebacterium. J Bacteriol Parasitol 4: 167. doi:10.4172/2155-9597.1000167
  22. Campbell HB, Oscar-Berman M, Giordano J, Beley TG, Barh D, Downs BW, Blum K. [2013]. Common Phenotype in Patients with Both Food and Substance Dependence: Case Reports. J Genet Syndr Gene Ther 4: 122. [PubMed: 23543232] 
  23. Blum K, Oscar-Berman, Barh D, Giordano J, Gold MS. [2013]. Dopamine Genetics and Function in Food and Substance Abuse. J Genet Syndr Gene Ther 4: 121. [PubMed: 23543775] 
  24. Blum K, Han D, Hauser M, Downs BW, Giordano J, Borsten J, Winchell E, Simpatico T, Madigan MA, Barh D. [2013]. Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS) as evidenced by Genetic Addiction Risk Score (GARS): A case study. The IIOAB Journal. 4 (1): 4-9.
  25. Barh D, Gupta K, Jain N, Khatri G, León-Sicairos N, Canizalez-Roman A, Tiwari S, Verma A, Rahangdale S, Shah Hassan S, Rodrigues Dos Santos A, Ali A, Carlos Guimarães L, Thiago Jucá Ramos R, Devarapalli P, Barve N, Bakhtiar M, Kumavath R, Ghosh P, Miyoshi A, Silva A, Kumar A, Narayan Misra A, Blum K, Baumbach J, Azevedo V. [2013]. Globally conserved inter-species bacterial PPIs based conserved host-pathogen interactome derived novel target in C. pseudotuberculosis, C. diphtheriae, M. tuberculosis, C. ulcerans, Y. pestis, and E. coli targeted by Piper betel compounds. Integrative Biology, 5: 495-509.  [PubMed: 23288366 ]  [IF: 4.5] GLOBAL MEDIA ATTRACTED
  26. Blum K, Oscar-Berman M, Stuller E, Miller D, Giordano J, Morse S, McCormick L, Downs WB, Waite RL, Barh D, Neal D, Braverman ER, Lohmann R, Borsten J, Hauser M, Han D, Liu Y, Helman M, Simpatico T. [2013]. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. J Addict Res Ther. 2012 Nov 27;3(5):139. [PubMed: 23926462] 
  27. Barh D, Barve N, Gupta K, Chandra S, Jain N, Tiwari S, Leon-Sicairos N, Canizalez-Roman A, Rodrigues Dos Santos A, Hassan SS, Almeida S, Thiago Jucá Ramos R, Augusto Carvalho de Abreu V, Ribeiro Carneiro A, de Castro Soares S, Luiz de Paula Castro T, Miyoshi A, Silva A, Kumar A, Narayan Misra A, Blum K, Braverman ER, Azevedo V. [2013]. Exoproteome and Secretome Derived Broad Spectrum Novel Drug and Vaccine Candidates in Vibrio cholerae Targeted by Piper betel Derived Compounds. PLoS ONE 8(1): e52773. [PubMed: 23382822] [IF: 4.09GLOBAL MEDIA ATTRACTED

 

 2012 

  1. Barh D, Jain N. A novel omics strategy to identify biomarkers for early diagnosis and classification of lung cancer. Journal of Thoracic Oncology, 2012,  7 (11), S5, Page No-S471 [IF: 3.66]  
  2. Miller M, Chen A, Stokes A, Silverman S, Bowirrat A, Manka M, Manka D, Miller D, Perrine K, Chen T, Bailey J, Downs BW, Waite R, Madigan M, Braverman E, Damle U, Kerner M, Giordano J, Morse S, Oscar-Berman M, Barh D, Blum K. [2012]. Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves Behavioral Outcomes in a Residential Addiction Treatment Program: A Pilot Study. Journal of Psychoactive Drugs. DOI:10.1080/02791072.2012.737727   [IF: 1.72]
  3. Barh D, Gupta K, Khatri G, Rahangdale S, Verma A. [2012]. An Integrative Omics Strategy for Identification of Skin Cancer Biomarkers. European Journal of Cancer, 48 (S6), 79. [IF: 5.53] 
  4. Santos AR, Carneiro A, Gala-García A, Pinto A, Barh D, Barbosa E, Aburjaile F, Dorella F, Rocha F, Guimarães L, Zurita-Turk M, Ramos R, Almeida S, Soares S, Pereira U, Abreu VC, Silva A, Miyoshi A, Azevedo V. [2012]. The Corynebacterium pseudotuberculosis in silico predicted pan-exoproteome. BMC Genomics; S5:S6. [PMID: 23095951] [IF: 4.07]
  5. Ramos RTJ, Carneiro AR, Azevedo V, Schneider MP, Barh D, Silva A. [2012]. Simplifier: a web tool to eliminate redundant NGS contigs. Bioinformation 8(20): 996-999. [IF: 1.15]
  6. Blum K, Giordano J, Oscar-Berman M, Bowirrat A, Simpatico T, Barh D. Diagnosis and Healing In Veterans Suspected of Suffering from Post-Traumatic Stress Disorder (PTSD) Using Reward Gene Testing and Reward Circuitry Natural Dopaminergic Activation. J Genet Syndr Gene Ther. 2012 May 31;3(3):1000116.  [PMID: 23264885]
  7. Hassan SS, Schneider MP, Ramos RT, Carneiro AR, Ranieri A, Guimarães LC, Ali A, Bakhtiar SM, Pereira Ude P, Dos Santos AR, Soares Sde C, Dorella F, Pinto AC, Ribeiro D, Barbosa MS, Almeida S, Abreu V, Aburjaile F, Fiaux K, Barbosa E, Diniz C, Rocha FS, Saxena R, Tiwari S, Zambare V, Ghosh P, Pacheco LG, Dowson CG, Kumar A, Barh D, Miyoshi A, Azevedo V, Silva A. [2012]. Whole-Genome Sequence of Corynebacterium pseudotuberculosis Strain Cp162, Isolated from Camel. J Bacteriol; 194(20):5718-19. [PMID: 23012291] [IF: 3.92] 
  8. Hemaiswarya S, Raja R, Carvalho IS, Ravikumar R, Zambare V, Barh D. [2012].  An Indian scenario on renewable and sustainable energy sources with emphasis on algae. Appl Microbiol Biotechnol; 96(5):1125-35. [PMID: 23070650] [IF: 3.42] 
  9. Carneiro AR, Ramos RT, Barbosa1 HPM, Schneider MPC, Barh D, Azevedo V, Silva A. [2012]. Quality of prokaryote genomes assembly: Indispensable issues of factors affecting prokaryote genome assembly quality. Gene. 505(2):365-7 [PMID: 22721771] [IF: 2.26]
  10. Zambare V. Zambare A, Barh D, Christopher LP. [2012]. Optimization of enzymatic hydrolysis of prairie cordgrass for improved ethanol production. J. Renewable Sustainable Energy 4, 033118 [IF: 0.885]
  11. Sá P, Pinto A, Ramos R, Coimbra N, Baraúna R, Azevedo V, Barh D, Silva A. [2012]. FunSys: Software for functional analysis of prokaryotic transcriptome and proteome. Bioinformation 8(11): 529-531.[PubMed: 22829724] [IF: 1.15]
  12. Blum K, Chen ALC, Giordano J, Borsten J, Chen TJH, Hauser M, Simpatico T, Femino J, Braverman ER, Barh D. [2012]. The Addictive Brain: All Roads Lead to Dopamine. Journal of Psychoactive Drugs, 44 (2), 134–143. [PubMed: 22880541] [IF: 1.72]
  13. Blum K, Oscar-Berman M, Bowirrat A, Giordano J, Madigan M, Braverman ER, Barh D, Hauser M, Borsten J, Simpatico T.. [2012]. Neuropsychiatric Genetics of Happiness, Friendships, and Politics: Hypothesizing Homophily (“Birds of a Feather Flock Together”) as a Function of Reward Gene Polymorphisms. J Genet Syndr Gene Ther 3:112. doi:10.4172/2157-7412.1000112 [PubMed: 23336089]
  14. Hollmann A, Saviello M, Delfederico L, Saraiva TDL, Barh D, Chandra S, Gupta K, Jain N, Zambare V, Kumar A, Misra AN, Christopher L, Azevedo V, Semorile L, Miyoshi A. [2012]. Tight controlled expression and secretion of Lactobacillus brevis SlpA in Lactococcus lactis. Biotechnology Letters; 34(7):1275-81. [PubMed: 22391736] [IF: 1.76]
  15. Chen ALC, Blum K, Chen TJH, Giordano J, Downs BW, Han D, Barh D, Braverman ER. [2012]. Correlation of the Taq1 Dopamine D2 Receptor Gene and Percent Body Fat in Obese and Screened Control Subjects: A Preliminary ReportFood & Function; 3(1):40-8. [PubMed: 22051885] [IF: 1.17]
  16. Barh D, Tiwari S, Bhat D. [2012]. Next-generation markers and targets in breast cancer: an integrative omics approach. Molecular Cancer Therapeutics. 10: (11), S1. [IF: 5.22]

2011

  1. Blum K, Chen ALC, Oscar-Berman M, Chen TJH, Lubar J, White N, Lubar J, Bowirrat A, Braverman E, Schoolfield J, Waite RL, Downs BW, Madigan M, Comings DE, Davis C, Kerner MM, Knopf J, Palomo T, Giordano JJ, Morse SA, Fornari F, Barh D, Femino J, Bailey JA.  [2011]. Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects: Selecting Appropriate Phenotypes for Reward Dependence BehaviorsInt J Env Res Public Health; 8(12):4425-4459. [PubMed: 22408582] [IF: 1.6]
  2. Blum K, Bagchi D, Bowirrat A, Downs WB, Waite RL, Madigan M, Downs JM, Giordano J, Morse S, Braverman ER, Polanin M, Barh D, Fornari F, Simpatico T. [2011]. Nutrigenomics of Neuradaptogen Amino-Acid-Therapy and Neurometabolic Optimizers: Overcoming carbohydrate bingeing and overeating through neurometabolic mechanisms. Functional Foods in Health and Disease; 9:310-378.
  3. Morse S, Giordano J, Perrine K, Downs BW, Waite RL, Madigan M, Bailey J, Braverman ER,  Damle U, Knopf J, Simpatico T, Moeller MD, Barh D, Blum K. [2011]. Audio Therapy Significantly Attenuates Aberrant Mood in Residential Patient Addiction Treatment: Putative Activation of Dopaminergic Pathways in the Meso-Limbic Reward Circuitry of Humans. J Addict Res Ther; S3:001. doi:10.4172/2155-6105.S3- 001
  4. Cerdeira LT, Carneiro AR, Bol E, Barbosa MS, Coimbra N, Ramos RTJ, Almeida SS, Santos AR, Soares SC, Pinto AC, Ali A, Barbosa E, Dorella FA, Rocha FS, Guimaraes LG, Figueira F, Ghosh P, Zambare V, Barve N, Tiwari S, Barh D, Miyoshi A, Schneider MPC, Azevedo V, Silva A. [2011]. Complete Genome Sequence of Corynebacterium pseudotuberculosis strain - CIP 52.97- isolated from Horse in Kenya. Journal of Bacteriology, 193(24):7025-6. [PubMed: 22123771] [IF: 3.92]
  5. Blum K, Chen TJH, Bailey J, Bowirrat A, Femino J, Chen ALC, Madigan M, Simpatico T, Morse S, Giordano J, Damle U, Kerner M, Braverman ER, Fornari F, Downs BW, Rector C, Barh D, Berman MC. [2011]. Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential? Molecular Neurobiology; 44(3):250-68. [PubMed: 21948099] [IF: 6.068]
  6. Blum K, Giordano J, Morse S, Anderson A, Carbaja J, Waite R, Downs B, Downs J, Madigan M, Barh D, Braverman E. [2011]. Hypothesizing Synergy between Acupuncture/ Auriculotherapy and Natural Activation of Mesolimbic Dopaminergic Pathways: Putative Natural Treatment Modalities for the Reduction of Drug Hunger and Relapse. IIOAB Letters.  DOI: 10.5195/iioablett.2011.9
  7. Cerdeira LT, Pinto AC, Cruz Schneider MP, Silva S, Santos AR, Vieira Barbosa EG, Ali A, Barbosa MS, Carneiro AR, Jucá Ramos RT, Santos O, Barh D, Barve N, Zambare V, Estevão S, Guimarães LC, de Castro S, Dorella FA, Rocha FS, Augusto V, Tauch A, Trost E, Miyoshi A, Azevedo V, Silva A. [2011]. Whole genome sequence of Corynebacterium pseudotuberculosis PAT10 of strain isolated from sheep in Patagonia, ArgentineJournal of Bacteriology, 193(22):6420-1. [PubMed: 22038974] [IF: 3.92]
  8. Santos A, Ali A, Barbosa E, Silva A, Miyoshi A, Barh D, Azevedo V. [2011]. The reverse vaccinology- a contextual overview. The IIOAB Journal; 2 (4): 8-15. [IC value: 5.16]
  9. Barh D, Jain N, Tiwari S, Parida BP, D'Afonseca V, Li L, Ali A, Santos AR, Guimarães LC, de Castro Soares S, Miyoshi A, Bhattacharjee A, Misra AN, Silva A, Kumar A, Azevedo V. [2011]. A novel comparative genomics analysis for common drug and vaccine targets in Corynebacterium pseudotuberculosis and other CMN group of human pathogensChemical Biology & Drug Design; 78(1):73-84.  [PubMed: 21443692] [IF: 2.47] 
  10. Barh D, Tiwari S, Jain N, Ali A, Santos AR, Misra AN, Azevedo V, and Kumar A. [2011]. In silico subtractive genomics for target identification in human bacterial pathogens. Drug Development Research; 72, 1-16[IF: 1.19]
  11. Barh D and Bhat D. [2011]. Integrative-omics based next-generation molecular markers and targets in colorectal cancer. Annals of Oncology, 21(Suppl 8):viii70. [IF: 6.45]

 

 2010

  1. Barh D, Bhat D, Viero C. [2010]. miReg: a resource for microRNA regulation. Journal of Integrative Bioinformatics; 7(1); 144. [PubMed: 20693604]
  2. Barh D, Misra AN, Kumar A, Vasco A. [2010]. A novel strategy of epitope design in Neisseria gonorrhoeae. Bioinformation; 5 (2), 77-85. [PubMed: 21346868] [IF: 1.15]
  3. Barh D, Sindhurani P, Bhattacharjee A. [2010]. NR2E1 inhibits cell proliferation in lung squamous cell carcinomas by regulating entry to cell cycle. Journal of Thoracic Oncology; 5 (5), S46. [IF: 4.54]  
  4. Barh D, Sindhurani P. [2010]. BLU is a classical tumor suppressor gene acts in DNA repair Pathway. Journal of Oncology Pharmacy Practice; 16(2), S34. [PubMed: 20351168]
  5. Barh D, Kumar A, Misra AN. [2010]. In silico identification of dual ability of N. gonorrhoeae ddl for developing drugs and vaccines against pathogenic Neisseria and other human pathogens. Journal of Proteomics & Bioinformatics; (3), 082-090.
  6. Barh D, Malhotra R, Ravi B, Sindhurani P. [2010]. microRNA Let-7: an emerging next-generation cancer therapeutic. Current Oncology; 17 (1), 70-80. [PubMed: 20179807] [IF: 2.47] 
  7. Shanthi PA, Singh P, Barh D, Venkatachalaiah G. [2010]. Comparative karyology based systematics of Euphlyctis hexadactylus and Euphlyctis cyanophlyctis. International Journal of Integrative Biology; 9 (1), 6-9.

 

2009

  1. Barh D. [2009]. In silico critical disease pathway mapping using public domain data and tools for development of personalized medicine. Advanced Biotech; June, 35-37.
  2. Barh D and Misra AN. [2009]. Epitope Design from Transporter Targets in N. gonorrhoeae. Journal of Proteomics & Bioinformatics; 2, 475-480.
  3. Barh D, Kumar A, Chatterjee S, Liloglou T. [2009]. Molecular features, markers, drug targets, and targeted therapeutics in cardiac myxoma. Current Cancer Drug Targets; 9 (6), 705-716.  [PubMed: 19754355] [IF: 4.3]  
  4. Barh D, Misra AN. [2009]. In silico Identification of membrane associated candidate drug targets in Neisseria gonorrhoeae. International Journal of Integrative Biology; 6(2), 65-67.
  5. Barh. D. [2009]. Targeted therapy in unusual cancers with special reference to cardiac myxoma and male breast cancer. New Biotechnology; Vol. 25, S11[IF: 2.8]
  6. Barh D, Kumar A, Misra AN. [2009]. Genomic Target Database (GTD): A database of potential targets in human pathogenic bacteria. Bioinformation; 4 (1), 50-51. [PubMed: 20011153 [IF: 1.15] 
  7. Barh D and Kumar A. [2009]. In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae. In Silico Biol.; Vol. 9, 0019. [PubMed: 20109152] [Cited in Nature Reviews Microbiology, 9(7): 2011
  8. Barh D, Parida S. [2009]. Cardiac myxoma: molecular markers, critical disease pathways, drug targets, and putative targeting miRs. Cancer Therapy; 7, 77-96.
  9. Barh D. [2009]. Biomarkers, critical disease pathways, drug targets, and alternative medicine in male breast cancer. Current Drug Targets; 10, 1-8. [PubMed: 19149530] [IF: 3.55] 

2008

  1. Barh D. [2008]. Let-7 replacement therapy: applicability in cancer. Cancer Therapy; 6, 939-984.
  2. Barh D, Parida S. Parida BP, Viswanathan G. [2008]. Let-7, miR-125, miR-205, and miR-296 are prospective therapeutic agents in breast cancer molecular medicine. Gene Therapy and Molecular Biology; 12, 189-206.
  3. Barh D, Mazumdar BC. [2008]. Comparative nutritive values of palm saps before and after their partial fermentation and effective use of wild date (P. sylvestris Roxb.) sap in treatment of anemia.  Research Journal of Medicine and Medical Sciences; 3(2): 173-176.
  4. Barh D, Viswanathan G. [2008]. Syzygium cumini inhibits growth and induces apoptosis in cervical cancer cell lines: a primary study. Ecancermedicalscience. 2008;2:83. [PubMed: 22275971] 

 

International conferences and meetings

  1. Barh D, Jain N. A novel omics strategy to identify biomarkers for early diagnosis and classification of lung cancer (P1-054). 5th  Asia Pacific Lung Cancer Conference and 3rd International Thymic Malignancy Interest Group Annual Meeting, November 25 – 28, 2012, Fukuoka, Japan (best Poster Award)
  2. Barh D, Gupta K, Khatri G, Rahangdale S, Verma A: An Integrative Omics Strategy for Identification of Skin Cancer Biomarkers (P258). 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; Nov 06-09, 2012; Dublin; Ireland
  3. Barh D, Tiwari S, Bhat D: Next-generation markers and targets in breast cancer: an integrative omics approach (B22). American Association for Cancer Research - National Cancer Institute - European Organization for Research and Treatment of Cancer (AACR-NCI- EORTC)-International Conference: Molecular Targets and Cancer Therapeutics: Nov 12-16, 2011; San Francisco, CA, USA
  4. Barh D and Bhat D: Integrative-omics based next-generation molecular markers and targets in colorectal cancer (P185).  35th ESMO Congress 8-12 October, 2010, Milan, Italy
  5. Barh D, Sindhurani P: BLU is a classical tumor suppressor gene acts in DNA repair Pathway. XII Symposium of the International Society of Oncology Pharmacy Practitioners. May 5-8, 2010. Prague, Czech Republic
  6. Barh D, Sindhurani P, Bhattacharjee A: NR2E1 inhibits cell proliferation in lung squamous cell carcinomas by regulating entry to cell cycle. (P111). 2nd European Lung Cancer Conference, 28 April – 1 May, 2010, Geneva, Switzerland 
  7. Barh D and Bhat D: Integrative omics based molecular insights, markers, and drug targets in lung cancer. (P12). International Society for Cellular Oncology (ISCO-2010 Congress), 17-19 March, 2010. Dresden, Germany 
  8. Barh D: Targeted therapy in unusual cancers with special reference to cardiac myxoma and male breast cancer. 14th European Congress on Biotechnology, 13–16 September, 2009. Barcelona, Spain   

Book Chapters

 

 

  1. Verma M, Barh D, Jain N. [2014]. Non-invasive Early Markers in Lung Cancer. In “Cancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis” ISBN 9781466584280Edt by Barh D, Carpi A, Verma M, Gunduz M. Taylor & Francis LLC, USA . (In Press)
  2. Bohra A, Jha UC, Singh B, Soren KR, Singh IP, Chaturvedi SK, Nadarajan N, and Barh D: [2014]. Omics Approaches in Pulses. In “OMICS Applications in Crop Science” ISBN 9781466585256, Edt by Barh D. Taylor & Francis LLC, USA . (In Press)
  3. Verma M, Barh D, Hassan S. [2014]. Next-generation Molecular Markers: Challenges, Applications, and Future Perspectives. In “Molecular Biology and Biotechnology” 6th Edition, Edt by David Whitehouse and Ralph Rapley. RSC Publishing, UK. (In Press)
  4. Verma M, Barh D, Azevedo V. [2014]. Molecular Biomarkers: Overview, Technologies, and Strategies. In “Molecular Biology and Biotechnology” 6th Edition, Edt by David Whitehouse and Ralph Rapley. RSC Publishing, UK. (In Press)
  5. Unal ZN, Kaya G, Barh D, Gunduz E, Gunduz M: [2014]. Omics of Male breast cancer. In “Omics approaches in Breast Cancer: Towards next-generation diagnosis, prognosis, and therapy”. ISBN 9788132208426, Edt by Barh D. Springer, India
  6. Verma M, Barh D. [2014]. Breast cancer biomarkers for risk assessment, screening, detection, diagnosis, and prognosis. In “Omics approaches in Breast Cancer: Towards next-generation diagnosis, prognosis, and therapy”. ISBN 9788132208426, Edt by Barh D. Springer, India
  7. Barh D, Yiannakopoulou UC, SALAWU UO, Chowbina S, Chaitankar V, Ghosh P, Azevedo V: [2013]. In Silico Models: From Simple Networks to Complex Diseases. In “Animal Biotechnology: Models in Discovery and Translation”, ISBN: 9780124160026, Edt by Verma and Singh. Elsevier, USA (In Press)
  8. Blum K, Han D, Giordano J, Lohmann R,  Braverman ER, Madigan MA,  Barh D, Femino J, Hauser M, Downs BW, Simpatico T: [2013]. Neurogenetics and Nutrigenomics of Reward Deficiency Syndrome (RDS): Stratification of Addiction Risk and Mesolimbic Nutrigenomic Manipulation of Hypodopaminergic Function. In “Omics for Personalized Medicine”  ISBN: 9788132211839 . Edt by Barh D, Dhawan D, Ganguly NK. Springer, India
  9. Chaitankar V, Barh D, Zambare V, Azevedo V, Ghosh P: [2013].  Computational Regulomics: Information Theoretic Approaches Towards Regulatory Network Inference. In “OMICS: Applications in Biomedical, Agricultural, and Environmental Sciences” ISBN 9781466562813. Edt by Barh D, Zambare V, Azevedo V. Taylor & Francis LLC, USA .
  10. Silva A, Abreua VD, Barh D, Miyoshi A, Azevedo V: [2013]. Next Generation Sequencing and Assembly of Bacterial Genomes. In “OMICS: Applications in Biomedical, Agricultural, and Environmental Sciences” ISBN 9781466562813. Edt by Barh D, Zambare V, Azevedo V. Taylor & Francis LLC, USA .
  11. Barh D, Agte V, Dhawan D, Agte V, and Padh H: [2012]. Cancer Biomarkers for Diagnosis, Prognosis, and Therapy. In “Molecular and Cellular Therapeutics”. ISBN: 9780470748145. Edt by David Whitehouse and Ralph Rapley. John Wiley & Sons Ltd, UK.
  12. Barh D, Ahmad S, and Bhattacharjee A: [2012]. In silico and ultra-high throughput screenings (uHTS) in drug discovery: an overview. In “Pharmaceutical Biotechnology (2nd Ed)”. ISBN: 978-3-527-32994-6. Edt by Oliver Kayser and Herbert Warzecha. Wiley-VCH Verlag GmbH & Co, Germany.
  13. López-Corrales NL, Miyoshi A, Azevedo V, Stuztman T, and Barh D: [2011]. Omics Approaches in Toxicology Research and Biomedical Applications. In “OMICS: Biomedical Perspectives and Applications”. ISBN: 9781439850084. Edt by Barh D, Median M, Blum K. CRC Press, USA.
  14. Barh D, Margaret AM, and Blum K: [2011]. Future Omics Perspective: Paving a Path to Optimization of Health. In “OMICS: Biomedical Perspectives and Applications”. ISBN: 9781439850084. Edt by Barh D, Median M, Blum K. CRC Press, USA. 

 

 

Research reference books

 

 

  1. Barh, Khan and Davies (Edts.) PlantOmics: The Omics of Plant Science. ISBN: 978-81-322-2171-5; ; First Ed: 2015; Springer, LLC. (In Press).
  2. Barh D and Gunduz M (Edts): Noninvasive Molecular Markers in Gynecologic Cancers. ISBN: 9781466569386; First Ed: Jan, 2015; Taylor & Francis LLC, USA.(In Press).
  3. Barh D (Edt): Omics approaches in breast cancer: towards next-generation diagnosis, prognosis, and therapy. ISBN: 9788132208426; First Ed: 2014; Springer LLC. 
  4. Barh DDhwan D and Ganguly NK (Edts): Omics for Personalized Medicine. First Ed: 2013; Springer LLC. (In Press)
  5. Barh D, Carpi A, Verma, M, and Gunduz M (Edts): Cancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis. ISBN: 9781466584280; First Ed: Sept, 2013;Taylor & Francis LLC, USA 
  6. Barh D, (Edts): OMICS Applications in Crop Science. ISBN: 9781466562813; First Ed: Oct, 2013. Taylor & Francis LLC, USA (In Press).
  7. Barh D, Zambare V, and Azevedo V (Edts): OMICS: Applications in Biomedical, Agricultural, and Environmental Sciences. ISBN 9781466562813; First Ed: March, 2013. Taylor & Francis LLC, USA 
  8. Barh D, Blum K, and Madigan MA (Edts): OMICS: Biomedical Perspectives and Applications ISBN: 9781439850084; First Ed: 2011-CRC Press, USA .
  9. Singh K, Vig AP, and Barh D: VERMICOMPOSTING: a boon for soil, plant, and environment.  ISBN: 9783844334425; First Ed: 2011; LAP Lambert Academic Publishing, Germany.
  10. Barh D, Das K, and Srivastava HC: Male Breast Cancer: Identifying and targeting critical disease signaling pathways towards development of personalized phytotherapy. ISBN: 9783843367592; First Ed: 2010; LAP Lambert Academic Publishing, Germany.
  11. Srivastava HC and Barh D: Genetics: Fundamentals and Applications. ISBN: 8181892631; First Ed: 2008; International Book Distributing Company, INDIA.

 

 
 

 

 More coming soon...........................